Overlæge Per Løgstrup Poulsen, overlæge Klavs Würgler Hansen, 1. reservelæge Peter Haulund Gæde & overlæge Peter Rossing
Århus Universitetshospital, Århus Sygehus, Medicinsk Afdeling M, Regionshospitalet Silkeborg, Medicinsk Afdeling, og Steno Diabetes Center, Glostrup
Summary
Hypertension in patients with diabetes
Ugeskr Læger 2009;171(24):2031-2034
The documentation for the beneficial effects of antihypertensive treatment in patients with diabetes is overwhelming. Most patients will require three or four antihypertensive drugs to achieve blood pressure (BP) goals. The regime should include an agent that blocks the renin angiotensin aldosterone system. Reduction in albuminuria during antihypertensive treatment is indicative of renal and cardiovascular protection. Thus, if the level of albuminuria remains high, the treatment should be intensified, even in the light of achieved BP goals. Options for intensification are dual blockade, supramaximal doses of ACE-I or ARB, or addition of aldosterone or renin-blocking agents. Long-term data are awaited regarding the optimal strategy for combination therapy. Patients on intensive antihypertensive treatment should be monitored regularly.